Expert opinion on the use of contraception in people with multiple sclerosis
Jan Hillert, Manuela Simoni(University of Modena and Reggio Emilia), Elisabetta Verdun di Cantogno(Ono Pharmaceutical (United States)), Maria K. Houtchens(Brigham and Women's Hospital), Zeliha Tülek(Nightingale Hospital), Kerstin Hellwig(St. Josef-Hospital), Riley Bove, Gabriele S. Merki‐Feld(University Hospital of Zurich), Rossella E. Nappi(Foundation Center), Egon Stenager(Copenhagen University Hospital), Lisa B. Haddad(Population Council), Scott Montgomery(St. Michael's Hospital), Heidi Thompson(Southern Health and Social Care Trust), Melinda Magyari(University of Copenhagen)
Cited by 9
Related Papers
Multiple Sclerosis Severity Score
|Neurology|2005|957
Multiple sclerosis progression: time for a new mechanism-driven framework
|The Lancet Neurology|2022|624
Diagnosis of multiple sclerosis: 2024 revisions of the McDonald criteria
|The Lancet Neurology|2025|314
Worldwide Incidence and Prevalence of Neuromyelitis Optica
|Neurology|2020|303